Yasodha Natkunam

Yasodha Natkunam publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yasodha Natkunam sits on this spectrum.

Yasodha Natkunam D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yasodha Natkunam sits on this spectrum.

Best Publications

• Multiplexed ion beam imaging of human breast tumors

  Michael Angelo;Sean C Bendall;Rachel Finck;Matthew B Hale

  1146
  Citations

• Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination

  Unknown

  693
  Citations

• CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

  Jay Y. Spiegel;Shabnum Patel;Lori Muffly;Nasheed M. Hossain

  531
  Citations

• International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

  A C Rawstron;N Villamor;M Ritgen;S Böttcher

  493
  Citations

• Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma

  Izidore S. Lossos;Carol D. Jones;Roger Warnke;Yasodha Natkunam

  368
  Citations

• Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.

  Zhen Fan;Yasodha Natkunam;Eric Bair;Robert Tibshirani

  351
  Citations

• Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays.

  Chih Long Liu;Wijan Prapong;Yasodha Natkunam;Ash Alizadeh

  292
  Citations

• The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.

  Chloé B. Steen;Bogdan A. Luca;Mohammad S. Esfahani;Armon Azizi

  292
  Citations

• Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial

  Bradley C. Ekstrand;Jennifer B. Lucas;Steven M. Horwitz;Zhen Fan

  283
  Citations

• Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.

  Andreas Rosenwald;Susanne Bens;Ranjana Advani;Sharon Barrans

  262
  Citations

• Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage.

  TuDung T Nguyen;Erich J Schwartz;Robert B West;Roger A Warnke

  262
  Citations

• Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and Immunohistochemistry

  Yasodha Natkunam;Roger A Warnke;Kelli Montgomery;Brunangelo Falini

  255
  Citations

• The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas

  Yasodha Natkunam;Shuchun Zhao;David Y. Mason;Jun Chen

  227
  Citations

• Atypical Cellular Disorders

  Kenneth L. McClain;Yasodha Natkunam;Steven H. Swerdlow

  220
  Citations

• LMO2 Protein Expression Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy With and Without Rituximab

  Yasodha Natkunam;Pedro Farinha;Eric D. Hsi;Christine P. Hans

  215
  Citations

• Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.

  Ash A. Alizadeh;Andrew J. Gentles;Alvaro J. Alencar;Chih Long Liu

  212
  Citations

• Natural Killer/Natural Killer-Like T-Cell Lymphoma, CD56+, Presenting in the Skin: An Increasingly Recognized Entity With an Aggressive Course

  Serena Mraz-Gernhard;Yasodha Natkunam;Richard T. Hoppe;Philip LeBoit

  204
  Citations

• Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status

  Margaretha G M Roemer;Margaretha G M Roemer;Ranjana H Advani;Robert A Redd;Geraldine S Pinkus

  198
  Citations

• Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis.

  Gabriela Gualco;Pollyanna Domeny-Duarte;Lucimara Chioato;Glen Barber

  168
  Citations

• Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas.

  Unknown

  60
  Citations